180 related articles for article (PubMed ID: 26287282)
21. Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer.
Terry S; Nicolaiew N; Basset V; Semprez F; Soyeux P; Maillé P; Vacherot F; Ploussard G; Londoño-Vallejo A; de la Taille A; Allory Y
Cancer; 2015 May; 121(9):1422-30. PubMed ID: 25639219
[TBL] [Abstract][Full Text] [Related]
22. Serum concentrations of prostate-specific antigen measured using immune extraction, trypsin digestion, and tandem mass spectrometry quantification of LSEPAELTDAVK peptide.
Klee EW; Bondar OP; Goodmanson MK; Trushin SA; Bergstralh EJ; Singh RJ; Anderson NL; Klee GG
Arch Pathol Lab Med; 2014 Oct; 138(10):1381-6. PubMed ID: 25268201
[TBL] [Abstract][Full Text] [Related]
23. The classification, functions and clinical use of different isoforms of HCG.
Stenman UH; Tiitinen A; Alfthan H; Valmu L
Hum Reprod Update; 2006; 12(6):769-84. PubMed ID: 16877746
[TBL] [Abstract][Full Text] [Related]
24. Determination of human chorionic gonadotropin.
Stenman UH; Alfthan H
Best Pract Res Clin Endocrinol Metab; 2013 Dec; 27(6):783-93. PubMed ID: 24275190
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
26. Identification of cross-reactive and restricted epitopes localized on human chorionic gonadotropin beta-subunit by monoclonal antibodies.
Saboor-Yaraghi AA; Ghods R; Gharagozlou S; Roohi A; Khoshnoodi J; Towfighi F; Jeddi-Tehrani M; Shokri F
Hybrid Hybridomics; 2004 Apr; 23(2):101-7. PubMed ID: 15165483
[TBL] [Abstract][Full Text] [Related]
27. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer.
Stenman UH; Leinonen J; Alfthan H; Rannikko S; Tuhkanen K; Alfthan O
Cancer Res; 1991 Jan; 51(1):222-6. PubMed ID: 1703033
[TBL] [Abstract][Full Text] [Related]
28. Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor.
Paju A; Stenman UH
Crit Rev Clin Lab Sci; 2006; 43(2):103-42. PubMed ID: 16517420
[TBL] [Abstract][Full Text] [Related]
29. Biology and function of tumor-associated trypsin inhibitor, TATI.
Stenman UH; Koivunen E; Itkonen O
Scand J Clin Lab Invest Suppl; 1991; 207():5-9. PubMed ID: 1780691
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies to human chorionic gonadotropin: implications for antigenic mapping, immunoradiometric assays, and clinical applications.
Norman RJ; Poulton T; Gard T; Chard T
J Clin Endocrinol Metab; 1985 Dec; 61(6):1031-8. PubMed ID: 2414309
[TBL] [Abstract][Full Text] [Related]
31. The Role of Human Chorionic Gonadotropin as Tumor Marker: Biochemical and Clinical Aspects.
Sisinni L; Landriscina M
Adv Exp Med Biol; 2015; 867():159-76. PubMed ID: 26530366
[TBL] [Abstract][Full Text] [Related]
32. Human chorionic gonadotropin in cancer.
Stenman UH; Alfthan H; Hotakainen K
Clin Biochem; 2004 Jul; 37(7):549-61. PubMed ID: 15234236
[TBL] [Abstract][Full Text] [Related]
33. Issues on standardization of immunoassays for prostate-specific antigen: a review.
Graves HC
Clin Invest Med; 1993 Dec; 16(6):415-24. PubMed ID: 7516830
[TBL] [Abstract][Full Text] [Related]
34. Expression of human chorionic gonadotropin in testicular germ cell tumors.
Lempiäinen A; Sankila A; Hotakainen K; Haglund C; Blomqvist C; Stenman UH
Urol Oncol; 2014 Jul; 32(5):727-34. PubMed ID: 24502963
[TBL] [Abstract][Full Text] [Related]
35. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
[TBL] [Abstract][Full Text] [Related]
36. Combination assay of urinary beta-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers.
Kinugasa M; Nishimura R; Koizumi T; Morisue K; Higashida T; Natazuka T; Nakagawa T; Isobe T; Baba S; Hasegawa K
Jpn J Cancer Res; 1995 Aug; 86(8):783-9. PubMed ID: 7559103
[TBL] [Abstract][Full Text] [Related]
37. Site-specific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatography--electrospray mass spectrometry.
Valmu L; Alfthan H; Hotakainen K; Birken S; Stenman UH
Glycobiology; 2006 Dec; 16(12):1207-18. PubMed ID: 16880503
[TBL] [Abstract][Full Text] [Related]
38. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies to the free beta-subunit of human chorionic gonadotropin define three distinct antigenic domains and distinguish between intact and nicked molecules.
Bidart JM; Troalen F; Lazar V; Berger P; Marcillac I; Lhomme C; Droz JP; Bellet D
Endocrinology; 1992 Oct; 131(4):1832-40. PubMed ID: 1382962
[TBL] [Abstract][Full Text] [Related]
40. Identification of a heterodimer-specific epitope present in human chorionic gonadotrophin (hCG) using a monoclonal antibody that can distinguish between hCG and human LH.
Gadkari RA; Roy S; Rekha N; Srinivasan N; Dighe RR
J Mol Endocrinol; 2005 Jun; 34(3):879-87. PubMed ID: 15956355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
